HPGC(SH:600664)2020-10-29 16:00Financial Performance - Net profit attributable to shareholders was CNY -372,663,728.15, compared to a profit of CNY 4,257,068.34 in the same period last year, representing a significant decline[16] - Operating revenue for the first nine months was CNY 7,649,073,314.94, down 9.63% year-on-year[16] - The basic earnings per share were CNY -0.13, compared to CNY 0.0017 in the same period last year[16] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY -441,417,462.70, a decrease of 1,238.97% year-on-year[16] - The company reported a net loss attributable to shareholders of ¥372,663,728.15 for the year-to-date period, with a forecast of continued negative net profit through the next reporting period[26] - Total operating revenue for Q3 2020 was approximately ¥2.84 billion, a decrease of 3.7% compared to ¥2.95 billion in Q3 2019[45] - Net profit for the first three quarters of 2020 was a loss of approximately ¥252.29 million, compared to a profit of ¥161.46 million in the same period of 2019[48] - The net profit for Q3 2020 was a loss of approximately ¥114.87 million, compared to a loss of ¥104.92 million in Q3 2019, indicating a worsening performance[58] Assets and Liabilities - Total assets at the end of the reporting period were CNY 11,631,739,004.77, a decrease of 6.96% compared to the end of the previous year[16] - As of September 30, 2020, the company's total assets amounted to approximately ¥11.63 billion, a decrease from ¥12.50 billion as of December 31, 2019, reflecting a decline of about 6.95%[37] - The company's current assets totaled approximately ¥7.49 billion, showing an increase from ¥7.31 billion year-over-year, representing a growth of about 2.54%[37] - Total liabilities increased to approximately ¥6.93 billion from ¥6.56 billion, reflecting a rise of about 5.67%[39] - The company's equity attributable to shareholders decreased to approximately ¥4.19 billion from ¥5.46 billion, a decline of about 23.23%[39] - Total liabilities reached approximately ¥5.24 billion from ¥4.29 billion year-over-year[45] - The company's total equity decreased to approximately ¥2.15 billion from ¥3.63 billion year-over-year, reflecting a decline in retained earnings[45] Cash Flow - The net cash flow from operating activities improved to CNY -72,943,528.85, a 51.03% increase compared to CNY -148,960,490.16 in the previous year[16] - Net cash flow from operating activities improved by 51.03% to -¥72,943,528.85 from -¥148,960,490.16, mainly due to increased collections from accounts receivable[24] - Net cash flow from investing activities improved by 95.29% to -¥63,888,776.27 from -¥1,357,420,880.64, primarily due to the completion of GNC convertible preferred stock subscription in the previous period[24] - Net cash flow from financing activities surged by 739.77% to ¥703,247,644.11 from ¥83,743,205.18, mainly due to new loans obtained[24] - Cash inflow from operating activities totaled ¥8,580,795,005.33, slightly up from ¥8,509,000,187.23 year-on-year[62] - Cash outflow for operating activities was ¥8,653,738,534.18, compared to ¥8,657,960,677.39 in the previous year[62] - The company reported a net cash increase of ¥566,631,981.31, contrasting with a net decrease of ¥1,422,491,228.84 in the same period last year[62] Shareholder Information - The number of shareholders at the end of the reporting period was 137,549[18] - The largest shareholder, Harbin Pharmaceutical Group Co., Ltd., held 1,173,237,023 shares, accounting for 46.80% of total shares[18] Government Support and Subsidies - The company received government subsidies amounting to CNY 55,737,931.44 during the reporting period[16] Impairments and Provisions - The company fully recognized impairment provisions for GNC convertible preferred stock investments totaling ¥2,048,661,920, impacting other comprehensive income[25] - The company reported a decrease in other comprehensive income, which worsened from approximately -¥845 million to -¥1.74 billion[39] Future Plans and Strategies - The company plans to actively take measures to reverse the unfavorable situation affecting its financial performance[26] - The company has plans for market expansion and new product development, although specific details were not disclosed in the financial report[35] - The company is focused on expanding its market presence and developing new products and technologies[69]